Hepatitis B Initiative Ofwashington Dc
Hepatitis B Initiative Ofwashington DC shows strong revenue growth and asset accumulation, with no reported officer compensation.
EIN: 205841637 · Washington, DC · NTEE: E70 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $1.6M |
| Total Expenses | $1.2M |
| Program Spending | 80% |
| Net Assets | $588K |
| Transparency Score | 85/100 |
Is Hepatitis B Initiative Ofwashington Dc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Hepatitis B Initiative Ofwashington Dc directs 80% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Hepatitis B Initiative Ofwashington Dc
Hepatitis B Initiative Ofwashington Dc (EIN: 205841637) is a nonprofit organization based in Washington, DC, classified under NTEE code E70. The organization reported total revenue of $1.6M and total assets of $314K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Hepatitis B Initiative Ofwashington Dc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Hepatitis B Initiative Ofwashington Dc is a mid-size nonprofit that has been operating for 19 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 23.0%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $1.1M |
| Total Expenses | $1.2M |
| Surplus / Deficit | $-53,737 |
| Total Assets | $633K |
| Total Liabilities | $45K |
| Net Assets | $588K |
| Operating Margin | -4.7% |
| Debt-to-Asset Ratio | 7.2% |
| Months of Reserves | 6.4 months |
Financial Health Grade: B
In 2023, Hepatitis B Initiative Ofwashington Dc reported a deficit of $54K with expenses exceeding revenue, holds 6.4 months of operating reserves (strong position), has a debt-to-asset ratio of 7.2% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Hepatitis B Initiative Ofwashington Dc's revenue has grown at a compound annual growth rate (CAGR) of 23.0%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +0.0% | +15.2% | -7.5% |
| 2022 | +14.6% | +27.9% | +25.9% |
| 2021 | +157.2% | +95.7% | +64.0% |
| 2020 | -20.7% | +23.9% | -10.1% |
| 2019 | -5.9% | -14.2% | +43.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2007 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Hepatitis B Initiative Ofwashington Dc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 80%
- fundraising: 5%
According to IRS 990 filings, Hepatitis B Initiative Ofwashington Dc allocates its expenses as follows: admin: 15%, programs: 80%, fundraising: 5%. With 80% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $54K, with expenses exceeding revenue.
- Debt-to-asset ratio: 7.2%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings. This suggests either a fully volunteer-led executive team or that executive compensation is categorized under other expense lines, which could impact the clarity of administrative cost reporting.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Hepatitis B Initiative Ofwashington Dc's IRS 990 filings:
- Consistent 0% officer compensation reported, which may obscure true leadership costs or raise questions about sustainability for a growing organization.
Strengths
The following positive indicators were identified for Hepatitis B Initiative Ofwashington Dc:
- Strong and consistent revenue growth over the past decade, from $189,770 in 2014 to $1,133,289 in 2023.
- Significant asset accumulation, growing from $123,945 in 2014 to $633,271 in 2023, indicating financial stability.
- Low liabilities relative to assets, demonstrating good financial management and solvency.
- Positive net assets in most years, showing the organization generally operates with a surplus.
Frequently Asked Questions about Hepatitis B Initiative Ofwashington Dc
Is Hepatitis B Initiative Ofwashington Dc a legitimate charity?
Hepatitis B Initiative Ofwashington Dc (EIN: 205841637) is a registered tax-exempt nonprofit based in Washington DC. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $1.6M. 1 red flag identified. 4 strengths noted. Financial health grade: B.
How does Hepatitis B Initiative Ofwashington Dc spend its money?
Hepatitis B Initiative Ofwashington Dc directs 80% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Hepatitis B Initiative Ofwashington Dc tax-deductible?
Hepatitis B Initiative Ofwashington Dc is registered as a tax-exempt nonprofit (EIN: 205841637). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Hepatitis B Initiative Ofwashington Dc's spending goes to programs?
Hepatitis B Initiative Ofwashington Dc directs 80% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Hepatitis B Initiative Ofwashington Dc compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), Hepatitis B Initiative Ofwashington Dc is above average for NTEE category E70 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Hepatitis B Initiative Ofwashington Dc located?
Hepatitis B Initiative Ofwashington Dc is headquartered in Washington, Washington DC and files with the IRS under EIN 205841637. It is classified under NTEE code E70.
How many years of IRS 990 filings does Hepatitis B Initiative Ofwashington Dc have?
Hepatitis B Initiative Ofwashington Dc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $1.6M in total revenue.
How does Hepatitis B Initiative Ofwashington DC manage to operate with 0% officer compensation?
The consistent reporting of 0% officer compensation across all filings (2014-2023) suggests that the organization's leadership may be entirely volunteer-based or compensated through other means not classified as 'officer compensation' on the 990, such as through program staff salaries. This is unusual for an organization of its growing size and revenue.
What is the trend in the organization's financial health?
HBI-DC has shown strong financial growth and health. Revenue increased from $189,770 in 2014 to $1,133,289 in 2023. Assets have also grown significantly from $123,945 in 2014 to $633,271 in 2023, while liabilities have remained relatively low, indicating good financial management and stability.
Is the organization efficient in its spending?
Based on the general financial trends, the organization appears to be efficient. While specific program vs. administrative spending percentages are not detailed in the provided data, the consistent growth in assets and relatively low liabilities suggest that funds are being managed effectively to support the organization's mission and build capacity.
Filing History
IRS 990 filing history for Hepatitis B Initiative Ofwashington Dc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Hepatitis B Initiative Ofwashington Dc's revenue has grown by 1101%, moving from $94K to $1.1M. Total assets increased by 2507.2% over the same period, from $24K to $633K. Total functional expenses rose by 1219.5%, from $90K to $1.2M. In its most recent filing year (2023), Hepatitis B Initiative Ofwashington Dc reported a deficit of $54K, with expenses exceeding revenue. The organization holds $45K in liabilities against $633K in assets (debt-to-asset ratio: 7.2%), resulting in net assets of $588K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $1.1M | $1.2M | $633K | $45K | — | — |
| 2022 | $1.1M | $1.0M | $685K | $43K | — | View 990 |
| 2021 | $989K | $805K | $544K | $29K | — | View 990 |
| 2020 | $384K | $411K | $332K | $6K | — | View 990 |
| 2019 | $485K | $332K | $369K | $16K | — | View 990 |
| 2018 | $515K | $387K | $258K | $35K | — | View 990 |
| 2017 | $392K | $402K | $165K | $40K | — | — |
| 2016 | $369K | $328K | $155K | $14K | — | View 990 |
| 2015 | $178K | $202K | $101K | $858 | — | View 990 |
| 2014 | $190K | $146K | $124K | $0 | — | View 990 |
| 2013 | $232K | $161K | $126K | $0 | — | View 990 |
| 2012 | $128K | $97K | $55K | $0 | — | View 990 |
| 2011 | $94K | $90K | $24K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $1.1M, expenses of $1.2M, and assets of $633K (revenue +0.0% year-over-year).
- 2022: Revenue of $1.1M, expenses of $1.0M, and assets of $685K (revenue +14.6% year-over-year).
- 2021: Revenue of $989K, expenses of $805K, and assets of $544K (revenue +157.2% year-over-year).
- 2020: Revenue of $384K, expenses of $411K, and assets of $332K (revenue -20.7% year-over-year).
- 2019: Revenue of $485K, expenses of $332K, and assets of $369K (revenue -5.9% year-over-year).
- 2018: Revenue of $515K, expenses of $387K, and assets of $258K (revenue +31.2% year-over-year).
- 2017: Revenue of $392K, expenses of $402K, and assets of $165K (revenue +6.3% year-over-year).
- 2016: Revenue of $369K, expenses of $328K, and assets of $155K (revenue +107.7% year-over-year).
- 2015: Revenue of $178K, expenses of $202K, and assets of $101K (revenue -6.3% year-over-year).
- 2014: Revenue of $190K, expenses of $146K, and assets of $124K (revenue -18.0% year-over-year).
- 2013: Revenue of $232K, expenses of $161K, and assets of $126K (revenue +80.2% year-over-year).
- 2012: Revenue of $128K, expenses of $97K, and assets of $55K (revenue +36.2% year-over-year).
- 2011: Revenue of $94K, expenses of $90K, and assets of $24K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Hepatitis B Initiative Ofwashington Dc:
Data Sources and Methodology
This transparency report for Hepatitis B Initiative Ofwashington Dc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.